 | Up a level |
Mulatero, Paolo; Wuerzner, Gregoire; Groessl, Michael; Sconfienza, Elisa; Damianaki, Aikaterini; Forestiero, Vittorio; Vogt, Bruno; Brunner, Hans; Gerlock, Teresa; Steele, Ronald; Schumacher, Christoph (2024). Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial. EClinicalMedicine, 71(102576) Elsevier 10.1016/j.eclinm.2024.102576
Pignatti, Emanuele; Kollar, Jakub; Hafele, Evelyn; Schuster, Daniela; Steele, Ronald E; Vogt, Bruno; Schumacher, Christoph; Groessl, Michael (2023). Structural and Clinical Characterization of CYP11B2 Inhibition by Dexfadrostat Phosphate. The journal of steroid biochemistry and molecular biology, 235(106409), p. 106409. Elsevier 10.1016/j.jsbmb.2023.106409
Mulatero, Paolo; Groessl, Michael; Vogt, Bruno; Schumacher, Christoph; Steele, Ronald Edward; Brooks, Ashley; Hossack, Stuart; Brunner, Hans-Rudolf (2023). CYP11B2 Inhibitor Dexfadrostat Phosphate Suppresses the Aldosterone-to-Renin Ratio, an Indicator of Sodium Retention, in Healthy Volunteers. British journal of clinical pharmacology, 89(8), pp. 2483-2496. Wiley-Blackwell 10.1111/bcp.15713
